Received Feb 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTPPVHBHPB | DTAP+IPV+HIB+HEPB (VAXELIS) | MSP VACCINE COMPANY | 2 | — | — |
Patient received an early dose of VAXELIS and is wondering about potential side effects; This non-serious spontaneous safety report, with reference number 2025SA036455, was received by partner on 04-FEB-2025 and forwarded to UBC on 05-FEB-2025 from other health professional. Off-label classification was added due to an early dose of Vaxelis being administered (inappropriate schedule of vaccine). Due to the nature of the event, the causality between the events 'Patient received an early dose of VAXELIS and is wondering about potential side effects' and Vaxelis was not applicable. Further information is expected.
Prophylaxis
PREVNAR; ENGERIX B; VARICELLA VACCINE; MMR